97 related articles for article (PubMed ID: 9379678)
1. NF-M trans-activates the human DNA topoisomerase II alpha promoter independently of c-Myb in HL-60 cells.
Brandt TL; Kroll DJ
Leuk Res; 1997 Aug; 21(8):711-20. PubMed ID: 9379678
[TBL] [Abstract][Full Text] [Related]
2. c-Myb trans-activates the human DNA topoisomerase IIalpha gene promoter.
Brandt TL; Fraser DJ; Leal S; Halandras PM; Kroll AR; Kroll DJ
J Biol Chem; 1997 Mar; 272(10):6278-84. PubMed ID: 9045645
[TBL] [Abstract][Full Text] [Related]
3. Topoisomerase II alpha promoter trans-activation early in monocytic differentiation of HL-60 human leukemia cells.
Fraser DJ; Brandt TL; Kroll DJ
Mol Pharmacol; 1995 Apr; 47(4):696-706. PubMed ID: 7723730
[TBL] [Abstract][Full Text] [Related]
4. Decreased CP-1 (NF-Y) activity results in transcriptional down-regulation of topoisomerase IIalpha in a doxorubicin-resistant variant of human multiple myeloma RPMI 8226.
Wang H; Jiang Zg; Wong YW; Dalton WS; Futscher BW; Chan VT
Biochem Biophys Res Commun; 1997 Aug; 237(2):217-24. PubMed ID: 9268689
[TBL] [Abstract][Full Text] [Related]
5. Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase II alpha messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone.
Harker WG; Slade DL; Parr RL; Holguin MH
Cancer Res; 1995 Nov; 55(21):4962-71. PubMed ID: 7585537
[TBL] [Abstract][Full Text] [Related]
6. Reduced level of ATF is correlated with transcriptional repression of DNA topoisomerase II alpha gene during TPA-induced differentiation of HL-60 cells.
Lim K; Lee JI; Yun KA; Son MY; Park JI; Yoon WH; Hwang BD
Biochem Mol Biol Int; 1998 Sep; 46(1):35-42. PubMed ID: 9784837
[TBL] [Abstract][Full Text] [Related]
7. Ras stimulates DNA topoisomerase II alpha through MEK: a link between oncogenic signaling and a therapeutic target.
Chen G; Templeton D; Suttle DP; Stacey DW
Oncogene; 1999 Nov; 18(50):7149-60. PubMed ID: 10597316
[TBL] [Abstract][Full Text] [Related]
8. Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation.
Adachi N; Nomoto M; Kohno K; Koyama H
Gene; 2000 Mar; 245(1):49-57. PubMed ID: 10713444
[TBL] [Abstract][Full Text] [Related]
9. CCAAT binding factor (CBF) binding mediates cell cycle activation of topoisomerase IIalpha. Conventional CBF activation domains are not required.
Hu Q; Bhattacharya C; Maity SN
J Biol Chem; 2002 Oct; 277(40):37191-200. PubMed ID: 12149265
[TBL] [Abstract][Full Text] [Related]
10. The effects of 1,4-benzoquinone on c-Myb and topoisomerase II in K-562 cells.
Singh R; Winn LM
Mutat Res; 2008 Oct; 645(1-2):33-8. PubMed ID: 18778717
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor.
Wang Q; Zambetti GP; Suttle DP
Mol Cell Biol; 1997 Jan; 17(1):389-97. PubMed ID: 8972219
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional analysis of the control region of the human DNA topoisomerase II alpha gene in drug-resistant cells.
Takano H; Ise T; Nomoto M; Kato K; Murakami T; Ohmori H; Imamura T; Nagatani G; Okamoto T; Ohta R; Furukawa M; Shibao K; Izumi H; Kuwano M; Kohno K
Anticancer Drug Des; 1999 Apr; 14(2):87-92. PubMed ID: 10405635
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugs.
Tolner B; Hartley JA; Hochhauser D
Mol Pharmacol; 2001 Apr; 59(4):699-706. PubMed ID: 11259613
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor-Y binding to the topoisomerase IIalpha promoter is inhibited by both the p53 tumor suppressor and anticancer drugs.
Joshi AA; Wu Z; Reed RF; Suttle DP
Mol Pharmacol; 2003 Feb; 63(2):359-67. PubMed ID: 12527807
[TBL] [Abstract][Full Text] [Related]
15. Role of an inverted CCAAT element in human topoisomerase IIalpha gene expression in ICRF-187-sensitive and -resistant CEM leukemic cells.
Morgan SE; Beck WT
Mol Pharmacol; 2001 Feb; 59(2):203-11. PubMed ID: 11160854
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
Harker WG; Slade DL; Parr RL; Feldhoff PW; Sullivan DM; Holguin MH
Cancer Res; 1995 Apr; 55(8):1707-16. PubMed ID: 7712479
[TBL] [Abstract][Full Text] [Related]
18. The histone deacetylase inhibitor sodium butyrate induces DNA topoisomerase II alpha expression and confers hypersensitivity to etoposide in human leukemic cell lines.
Kurz EU; Wilson SE; Leader KB; Sampey BP; Allan WP; Yalowich JC; Kroll DJ
Mol Cancer Ther; 2001 Dec; 1(2):121-31. PubMed ID: 12467229
[TBL] [Abstract][Full Text] [Related]
19. CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure.
Coustry F; Hu Q; de Crombrugghe B; Maity SN
J Biol Chem; 2001 Nov; 276(44):40621-30. PubMed ID: 11514576
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a potential regulatory role for inverted CCAAT boxes in the human topoisomerase II alpha promoter.
Herzog CE; Zwelling LA
Biochem Biophys Res Commun; 1997 Mar; 232(3):608-12. PubMed ID: 9126321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]